University of Miami (UM) is in the midst of an academic and scientific renaissance. At the root of this sweeping transformation is an infusion of exceptional scientific talent with substantial external funding, a rich track record of collaborative team science, and the firsthand knowledge of how to build innovative research programs. The Miami Clinical Translational Science Institute (CTSI) will leverage these strengths to connect clinical and translational science with service and community; foster interdisciplinarity; attract our best and brightest clinician scientists to research; nurture a clinical research workforce, and manage resources to sustain success. With the ultimate goal of improving health, we will catalyze research opportunities to better understand and mitigate the factors that affect susceptibility, progression, and adverse consequence of disease in our majority minority patient population. Interdisciplinary research will be built on solid bidirectional collaboration with our diverse communities. We will harmonize core services into highly functional consolidated platforms with standardized policies and procedures and unified governance bonded by our bioinformatics platform. We will advance research translation in culturalized health sciences. We use the term culturalize to denote that, in a community that is 80% racial/ethnic minorities, our work is exposed to and influenced by the culture of our highly diverse faculty, staff, patients, and study participants. We will leverage the benefits of our CITI program, which remains the international standard for training in responsible conduct of research. We have designed the modern form-meets-function Research Commons, the physical home of the CTSI. Collaboration is high across the CTSI, including partnerships among UM Schools, Jackson Health System, Miami VA and the University of Puerto Rico. Ultimately, the measure of our success will be our ability to improve the health of our community.

Public Health Relevance

UM will bring together under the single umbrella ofthe Miami Clinical Translational Science Institute (CTSI) the resources, talent and scientific expertise found in our numerous internationally recognized Schools, Departments, Institutes and Centers. The CTSI will enable UM to best serve the health care needs of its diverse community while growing the size and quality of our translational research workforce and speeding the delivery of scientific discoveries to application.

National Institute of Health (NIH)
National Center for Advancing Translational Sciences (NCATS)
Linked Specialized Center Cooperative Agreement (UL1)
Project #
Application #
Study Section
Special Emphasis Panel (ZRR1)
Program Officer
Talbot, Bernard
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Miami School of Medicine
Public Health & Prev Medicine
Schools of Medicine
Coral Gables
United States
Zip Code
Smith, Steven M; McAuliffe, Kathryn; Hall, Jaclyn M et al. (2018) Hypertension in Florida: Data From the OneFlorida Clinical Data Research Network. Prev Chronic Dis 15:E27
Lu, Min; Sadiq, Saad; Feaster, Daniel J et al. (2018) Estimating Individual Treatment Effect in Observational Data Using Random Forest Methods. J Comput Graph Stat 27:209-219
Chang, Aileen; Patberg, Elizabeth; Cueto, Victor et al. (2018) Community Health Workers, Access to Care, and Service Utilization Among Florida Latinos: A Randomized Controlled Trial. Am J Public Health 108:1249-1251
Lewis, John E; Atlas, Steven E; Higuera, Oscar L et al. (2018) The Effect of a Hydrolyzed Polysaccharide Dietary Supplement on Biomarkers in Adults with Nonalcoholic Fatty Liver Disease. Evid Based Complement Alternat Med 2018:1751583
Vendrame, Francesco; Padilla, Nathalia; Peixoto, Eduardo et al. (2018) Chronic Liraglutide Administration Fails to Suppress Postprandial Glucagon Levels in Type 1 Diabetic Islet Allograft Recipients With Graft Dysfunction. Transplantation 102:e39-e40
Rech, Andrew J; Balli, David; Mantero, Alejandro et al. (2018) Tumor Immunity and Survival as a Function of Alternative Neopeptides in Human Cancer. Cancer Immunol Res :
Mitrofanova, Alla; Molina, Judith; Varona Santos, Javier et al. (2018) Hydroxypropyl-?-cyclodextrin protects from kidney disease in experimental Alport syndrome and focal segmental glomerulosclerosis. Kidney Int 94:1151-1159
Howe, George W; Pantin, Hilda; Perrino, Tatiana (2018) Programs for Preventing Depression in Adolescence: Who Benefits and Who Does Not? An Introduction to the Supplemental Issue. Prev Sci 19:1-5
Galor, Anat; Moein, Hamid-Reza; Lee, Charity et al. (2018) Neuropathic pain and dry eye. Ocul Surf 16:31-44
Dazard, Jean-Eudes; Ishwaran, Hemant; Mehlotra, Rajeev et al. (2018) Ensemble survival tree models to reveal pairwise interactions of variables with time-to-events outcomes in low-dimensional setting. Stat Appl Genet Mol Biol 17:

Showing the most recent 10 out of 153 publications